Expression of the heparin-binding growth factor midkine in the cerebrospinal fluid of patients with neurological disorders

Internal Medicine

Volumn 47, Issue 2, 2008, Pages 83-89

  Yoshida, Yoshihiro ^a   Ikematsu, Shinya ^b   Muramatsu, Hisako ^c   Sakakima, Harutoshi ^a   Mizuma, Nobuhisa ^a   Matsuda, Fumiyo ^a   Sonoda, Ken ^d   Umehara, Fujio ^a   Ohkubo, Ryuichi ^a   Matsuura, Eiji ^a   Goto, Masamichi ^a   Osame, Mitsuhiro ^a   Muramatsu, Takashi ^c  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b MEIJI DAIRIES CORPORATION   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Kagoshima City Hospital   (Japan)

Author keywords

Cerebral infarction; CSF; Cytokine; Meningitis; MK; Neurotrophic factor

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR; MIDKINE; NEUROTROPHIC FACTOR;

ADOLESCENT; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOPSY; BACTERIAL MENINGITIS; BRAIN INFARCTION; BRAIN TISSUE; CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; CHOROID PLEXUS; CONTROLLED STUDY; CRYPTOCOCCAL MENINGITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FISHER EXACT TEST; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NEUROLOGIC DISEASE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REGRESSION ANALYSIS; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; TUBERCULOUS MENINGITIS; VIRUS MENINGITIS; WESTERN BLOTTING; ANIMAL; CASE CONTROL STUDY; CEREBROSPINAL FLUID; CHEMISTRY; GENE EXPRESSION PROFILING; MENINGITIS; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; CEREBROSPINAL FLUID; CHOROID PLEXUS; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MENINGITIS; MIDDLE AGED; RATS;

EID: 38749124065     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.47.0260     Document Type: Article

References (37)

1. Iwasaki W, Nagata. K, Hatanaka H,, et al. Solution structure of midkine, a new heparin-binding growth factor. EMBO J 16: 6936-6946, 1997.
2. Kadomatsu K, Tomomura M, Muramatsu. T. cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 151: 1312-1318, 1988.
3. Tomomura M, Kadomatsu K, Matsubara S, Muramatsu T. A retinoic acid-responsive gene, MK, found in the teratocarcinoma system. Heterogeneity of the transcript and the nature of the translation product. J Biol Chem 265: 10765-10770, 1990.
4. Li YS, Milner PG, Chauhan AK, et al. Cloning and expression of a developmentally regulated protein: that induces mitogenic and neurite outgrowth activity. Science 250: 1690-1694, 1990.
5. Merenmies J, Rauvala H. Molecular cloning of the l8kDa growth-associated protein of developing brain. J Biol Chem 265: 16721-16724, 1990.
6. Kadomatsu K, Huang RP, Suganuma T, Murata F, Muramatsu T. A retinoic acid responsive gene MK found in the teratocarcinoma system is expressed in spatially and temporally controlled manner during mouse embryogenesis. J Cell Biol 110: 607-616, 1990.
7. Mitsiadis TA, Salmivirta M, Muramatsu T, et al. Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis. Development 121: 37-51, 1995.
8. Sun XZ, Inoue M, Fukui Y, et al. An immunohistochemical study of radial glial cells in the mouse brain prenatally exposed to γ-irradiation. J Neuropathol Exp Neurol 56: 1339-1348, 1997.
9. Muramatsu H, Shirahama H, Yonezawa S, Maruta H, Muramatsu T. Midkine (MK), a retinoic acid-inducible growth/differentiation factor: immunochemical evidence for the function and distribution. Dev Biol 159: 392-402, 1993.
10. Kojima S, Muramatsu H, Amanuma H, Muramatsu T. Midkine enhances fibrinolytic activity of bovine endothelial cells. J Biol Chem 270: 9590-9596, 1995.
11. Michikawa M, Kikuchi S, Muramatsu H, Muramatsu T, Kim SU. Retinoic acid responsive gene product, midkine (MK), has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture. J Neurosci Res 35: 530-539, 1993.
12. Horiba M, Kadomatsu K, Nakamura E, et al. Neointima formation in a restenosis model is suppressed in midkine-deficient mice. J Clin Invest 105: 489-495, 2000.
13. Takada T, Toriyama K, Muramatsu, H, Song XJ, Torii S, Muramatsu. T. Midkine, a retinoic acid-inducible heparin-binding cytokine in inflammatory responses: chemotactic activity to neutrophils and association with inflammatory synovitis. J Biochem 122: 453-458, 1997.
14. Maeda N, Ichihara-Tanaka K, Kimura T, Kadomatsu K, Muramatsu T, Noda M. A receptor-like protein tyrosine phosphatase PTPς/RPTPβ binds a heparin binding growth factor midime: Involvement of arginine 78 of midkine in the high affinity binding to PTPς. J Biol Chem 274: 12474-12479, 1999.
15. Nakamura E, Kadomatsu K, Yuasa S, et al. Disruption of the midkine gene (Mdk) resulted in altered expression of a calcium binding protein in the hippocampus of infant mice and their abnormal behavior. Genes Cells 3: 811-822, 1998.
16. Wang S, Yoshida Y, Goto M, et al. Midkine is produced by astrocytes in the early stage of cerebral infarction. Dev Brain Res 106: 205-209, 1998.
17. Yoshida Y, Goto M, Tsutsui J, et al. Midkine is present in the early stage of cerebral infarct. Dev Brain Res 85: 25-30, 1995.
18. Mochizuki R, Takeda A, Sato N, et al. Induction of midkine expression in reactive astrocytes following rat trasient forebrain ischemia. Exp Neurol 149: 73-78, 1998.
19. Unoki K, Ohba N, Arimura, H, Muramatsu H, Muramatsu T. Rescue of photoreceptors from the damaging effects of constant light by midkine, a retinoic acid responsive gene product. Invest Ophthalmol Vis Sci 35: 4063-4068, 1994.
20. Sato W, Kadomatsu K, Yazawa Y, et al. Midkine is involved in neurtrophil infiltration into the tubulointerstitium in ischemic renal injury. J Immunol 67: 3463-3469, 2001.
21. Ikematsu S, Aridome K, Kikuchi M, et al. Serum midkine levels are increased in patients with various types of carcinomas. Br J Cancer 83: 701-706, 2000.
22. Umehara F, Izumo S, Nakagawa M, et al. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesion in HTLV-IAssociated myelopathy. J Neuropathol Exp Neurol 52: 424-430, 1993.
23. Yasuhara O, Muramatsu H, Kim SU, Muramatsu T, Maruta H, McGeer PL. Midkine, a novel neurotrophic factor, is present in senile plaques of Alzheimer disease. Biochem Biophys Res Commun 192: 246-251, 1993.
24. Kaname T, Kadomatsu K, Aridome K, et al. The expression of truncated MK in human tumors. Biochem. Biophys Res Commun 219: 256-260, 1996.
25. Nockher WA, Renz H. Neurotrophins in clinical diagnostics: pathology and laboratory investigation. Clin Chim. Acta 352: 49-74, 2005.
26. Dalal I, Tzhori S, Somekh E, Mandeberg A, Levine A, Ballin A. Cytokine profile in cerebrospinal fluid of children with echovirus type 4 meningitis. Pediatr Neurol 29: 312-316, 2003.
27. Kornelisse RF, Savelkoul HFJ, Mulder PHG, et al. Interleukin-10 and soluble tumor necrosis factor receptors in cerebrospinal fluid of children with bacterial meningitis. J Infect Dis 173: 1498-1502, 1996.
28. Ichiyama T, Shoji H, Kato M, et al. Cerebrospinal fluid levels of cytokines and soluble tumour necrosis factor receptor in acute disseminated encephalomyelitis. Eur J Pediatr 161: 133-137, 2002.
29. Ishiguro A, Suzuki Y, Inaba Y. et al. The production of IL-8 in cerebrospinal fluid in aseptic meningitis of children. Clin Exp Immunol 109: 426-430, 1997.
30. Fassbender K, Mielke O, Bertsch T. et al. Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases. Neurology 53: 1104-1106, 1995.
31. Ohga S, Okada K, Ueda & et al. Cerebrospinal fluid cytokine levels and dexamethasone therapy in bacterial meningitis. J Infect 39: 55-60, 1999.
32. Van Deuren M, van der Ven-Jongekrijg J, Vannier E, et al. The pattern of interleukin-1beta (IL-1beta) and its modulating agents IL-1 receptor antagonist and 1L-1 soluble receptor type II in acute meningococcal infections. Blood 90: 1101-1108, 1997.
33. Nakanishi T, Kadomatsu K, Okamoto T, et al. Expression of syndecan-1 and -3 during embryogenesis of the central nervous system in relation to binding with midkine. J Biochem 121: 197-205, 1997.
34. Muramatsu H, Zou K, Sakaguchi N, Ikematsu S, Sakuma S, Muramatsu T. LDL receptor-related protein as a component of the midkine receptor. Biochem Biophys Res Commun 270: 936-941, 2000.
35. Sakakima H, Yoshida Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T. Midkine expression in rat spinal motor neurons following sciatic nerve injury. Dev Barin Res 153: 251-260, 2004.
36. Sato J, Muramatsu H, Moretto G, et al. Midkine that promotes survival of human neurons is produced by fetal human astrocytes in culture. Dev Brain Res 75: 201-205, 1993.
37. Sakakima H, Yoshida Y, Muramatsu T, et al. Traumatic injury-induced midkine expression in the adult rat spinal cord during the early stage. J Neurotrauma 21: 471-477, 2003.